Umbilical cord blood-derived CD11c(+) dendritic cells could serve as an alternative allogeneic source of dendritic cells for cancer immunotherapy

INTRODUCTION: Allogenic dendritic cells (DCs) generated from healthy donors, who are complete or partially HLA-matched, have been used for clinical trials. One of the sources for allogenic DCs is umbilical cord blood (UCB) cells. However, as far as cord blood cells are concerned, looking at their na...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumar, Jeetendra, Kale, Vaijayanti, Limaye, Lalita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4583174/
https://www.ncbi.nlm.nih.gov/pubmed/26407613
http://dx.doi.org/10.1186/s13287-015-0160-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4583174/
https://www.ncbi.nlm.nih.gov/pubmed/26407613
http://dx.doi.org/10.1186/s13287-015-0160-8

Ejemplares similares